In clinical practice, complex patients with comorbidity of mood and anxiety disorders are arguably the norm. These volumes focus on this area, providing up-to-date reviews of the conceptual issues that confront the clinician when evaluating these patients Concise and easy-to-read, they also present a practical approach to the management and treatment of patients with comorbid mood and anxiety disorders.
David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs.